Lycia Therapeutics, Inc.

Lycia Therapeutics, Inc. financial statements

Lycia Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 6.74MEODHD
Net income−USD 36.46MEODHD
Cash and equivalentsUSD 19.27MEODHD

Lycia Therapeutics, Inc. financials on 6ix · Lycia Therapeutics, Inc. on 6ix